Why should we monitor for hematologic adverse drug reactions to oxcarbazepine?
Gespeichert in:
Veröffentlicht in: | Korean journal of pediatrics 2019, Vol.62 (8), p.299-300 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | kor |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 300 |
---|---|
container_issue | 8 |
container_start_page | 299 |
container_title | Korean journal of pediatrics |
container_volume | 62 |
creator | Jang, Gwang Cheon |
description | |
format | Article |
fullrecord | <record><control><sourceid>kisti</sourceid><recordid>TN_cdi_kisti_ndsl_JAKO201928963900584</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JAKO201928963900584</sourcerecordid><originalsourceid>FETCH-kisti_ndsl_JAKO2019289639005843</originalsourceid><addsrcrecordid>eNqNyrsKwjAYQOEgCtbLO_yLYyFJ75OIKKKgi-BYYpu20TSRJPX29Dr4AA6Hbzk95FGcUT-hUdpHHkmC1Cc4JkM0svaCcRyGMfXQ_tS8wDa6kyU8OLRaCacNVN8a3jKnpa5FAay8c2M5lKarwXBWOKGVBadBPwtmzuzNb0Lx-QQNKiYtn_4co9l6dVxu_KuwTuSqtDLfLnYHiklG0ywOMoyjNAz-_T66vD5A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Why should we monitor for hematologic adverse drug reactions to oxcarbazepine?</title><source>KoreaMed Synapse</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>KoreaMed Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Jang, Gwang Cheon</creator><creatorcontrib>Jang, Gwang Cheon</creatorcontrib><identifier>ISSN: 1738-1061</identifier><identifier>EISSN: 2092-7258</identifier><language>kor</language><ispartof>Korean journal of pediatrics, 2019, Vol.62 (8), p.299-300</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,4021</link.rule.ids></links><search><creatorcontrib>Jang, Gwang Cheon</creatorcontrib><title>Why should we monitor for hematologic adverse drug reactions to oxcarbazepine?</title><title>Korean journal of pediatrics</title><addtitle>Korean journal of pediatrics</addtitle><issn>1738-1061</issn><issn>2092-7258</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>JDI</sourceid><recordid>eNqNyrsKwjAYQOEgCtbLO_yLYyFJ75OIKKKgi-BYYpu20TSRJPX29Dr4AA6Hbzk95FGcUT-hUdpHHkmC1Cc4JkM0svaCcRyGMfXQ_tS8wDa6kyU8OLRaCacNVN8a3jKnpa5FAay8c2M5lKarwXBWOKGVBadBPwtmzuzNb0Lx-QQNKiYtn_4co9l6dVxu_KuwTuSqtDLfLnYHiklG0ywOMoyjNAz-_T66vD5A</recordid><startdate>2019</startdate><enddate>2019</enddate><creator>Jang, Gwang Cheon</creator><scope>JDI</scope></search><sort><creationdate>2019</creationdate><title>Why should we monitor for hematologic adverse drug reactions to oxcarbazepine?</title><author>Jang, Gwang Cheon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-kisti_ndsl_JAKO2019289639005843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>kor</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jang, Gwang Cheon</creatorcontrib><collection>KoreaScience</collection><jtitle>Korean journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jang, Gwang Cheon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Why should we monitor for hematologic adverse drug reactions to oxcarbazepine?</atitle><jtitle>Korean journal of pediatrics</jtitle><addtitle>Korean journal of pediatrics</addtitle><date>2019</date><risdate>2019</risdate><volume>62</volume><issue>8</issue><spage>299</spage><epage>300</epage><pages>299-300</pages><issn>1738-1061</issn><eissn>2092-7258</eissn><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1738-1061 |
ispartof | Korean journal of pediatrics, 2019, Vol.62 (8), p.299-300 |
issn | 1738-1061 2092-7258 |
language | kor |
recordid | cdi_kisti_ndsl_JAKO201928963900584 |
source | KoreaMed Synapse; DOAJ Directory of Open Access Journals; PubMed Central Open Access; KoreaMed Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
title | Why should we monitor for hematologic adverse drug reactions to oxcarbazepine? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A54%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-kisti&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Why%20should%20we%20monitor%20for%20hematologic%20adverse%20drug%20reactions%20to%20oxcarbazepine?&rft.jtitle=Korean%20journal%20of%20pediatrics&rft.au=Jang,%20Gwang%20Cheon&rft.date=2019&rft.volume=62&rft.issue=8&rft.spage=299&rft.epage=300&rft.pages=299-300&rft.issn=1738-1061&rft.eissn=2092-7258&rft_id=info:doi/&rft_dat=%3Ckisti%3EJAKO201928963900584%3C/kisti%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |